NCT03513432

Brief Summary

Our aim is to assess the effects of moderate consumption of beer and non-alcoholic beer on gut microbiota and biochemical biomarkers in healthy adults.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for not_applicable healthy-volunteers

Timeline
Completed

Started Mar 2018

Typical duration for not_applicable healthy-volunteers

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 26, 2018

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

April 12, 2018

Completed
19 days until next milestone

First Posted

Study publicly available on registry

May 1, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2018

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2019

Completed
Last Updated

May 28, 2019

Status Verified

May 1, 2019

Enrollment Period

7 months

First QC Date

April 12, 2018

Last Update Submit

May 23, 2019

Conditions

Keywords

Gut microbiotaBeerAlcoholCardiovascular disease

Outcome Measures

Primary Outcomes (1)

  • Changes in intestinal microbiota from baseline

    at visit 1 (after 1-week run-in period) and at visit 2 (after 4-week intake period)

Secondary Outcomes (8)

  • Changes in fasting serum total cholesterol from baseline

    at visit 1 (after 1-week run-in period) and at visit 2 (after 4-week intake period)

  • Changes in fasting serum triglycerides from baseline

    at visit 1 (after 1-week run-in period) and at visit 2 (after 4-week intake period)

  • Changes in fasting serum cHDL from baseline

    at visit 1 (after 1-week run-in period) and at visit 2 (after 4-week intake period)

  • Changes in fasting serum cLDL from baseline

    at visit 1 (after 1-week run-in period) and at visit 2 (after 4-week intake period)

  • Changes in Homeostasis Model Assessment-Insulin Resistance (HOMA-IR) from baseline

    at visit 1 (after 1-week run-in period) and at visit 2 (after 4-week intake period)

  • +3 more secondary outcomes

Study Arms (3)

Beer with 5.20 % alcohol

EXPERIMENTAL

330 ml beer (5.20 % alcohol)/day

Dietary Supplement: Beer with 5.20 % alcohol

Non-alcoholic beer with 0.45 % alcohol

EXPERIMENTAL

330 ml non-alcoholic beer (0.45 % alcohol)/day

Dietary Supplement: Non-alcoholic beer with 0.45 % alcohol

Non-alcoholic beer with 0.00 % alcohol

EXPERIMENTAL

330 ml non-alcoholic beer (0.00 % alcohol)/day

Dietary Supplement: Non-alcoholic beer with 0.00 % alcohol

Interventions

Beer with 5.20 % alcoholDIETARY_SUPPLEMENT

330 ml beer (5.20 % alcohol)/day during 4 weeks

Beer with 5.20 % alcohol

330 ml non-alcoholic beer (0.45 % alcohol)/day during 4 weeks

Non-alcoholic beer with 0.45 % alcohol

330 ml nonalcoholic beer (0.00 % alcohol)/day during 4 weeks

Non-alcoholic beer with 0.00 % alcohol

Eligibility Criteria

Age18 Years - 65 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult men (18-65 years);
  • Healthy volunteers free of chronic diseases with relevant effect on gastrointestinal system;
  • Without a diagnosis of any digestive disease including functional bowel disorders such as IBS;
  • Moderate alcohol consumers;
  • Willing and able to provide written informed consent.

You may not qualify if:

  • Documented cardiovascular disease (ischaemic heart disease - angina or recent or old myocardial infarction or previous or cerebral vascular accident, peripheral vascular disease);
  • With diabetes or other relevant metabolic diseases;
  • With any known infectious diseases, namely infections with HIV, Hepatitis B or C virus;
  • Intake of antibiotics in the last 4 weeks and laxatives in the last 2 weeks;
  • Subjects with history of drug, alcohol or other substances abuse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculdade de Ciências Médicas da Universidade NOVA de Lisboa

Lisbon, Portugal

Location

MeSH Terms

Conditions

Cardiovascular Diseases

Interventions

BeerEthanol

Intervention Hierarchy (Ancestors)

Alcoholic BeveragesBeveragesDiet, Food, and NutritionPhysiological PhenomenaFermented BeveragesFermented FoodsFood and BeveragesAlcoholsOrganic Chemicals

Study Officials

  • Conceição Calhau, PhD

    NOVA Medical School

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This is a three-arm parallel-group, randomized controlled study to evaluate the effect of consumption of beer with or without alcohol (5.20 %, 0.45 % and 0.00 %), during 4 weeks, on healthy individuals. The study will focus on the effects of beer on microbiota and biochemical biomarkers in healthy human volunteers.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 12, 2018

First Posted

May 1, 2018

Study Start

March 26, 2018

Primary Completion

October 15, 2018

Study Completion

May 15, 2019

Last Updated

May 28, 2019

Record last verified: 2019-05

Locations